Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 1
2006 2
2008 1
2009 2
2010 2
2011 3
2012 1
2013 4
2014 3
2015 5
2016 7
2017 8
2018 4
2019 10
2020 10
2021 7
2022 8
2023 5
2024 7
2025 7
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of Butantan-DV in participants aged 2-59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil.
Nogueira ML, Cintra MAT, Moreira JA, Patiño EG, Braga PE, Tenório JCV, de Oliveira Alves LB, Infante V, Silveira DHR, de Lacerda MVG, Pereira DB, da Fonseca AJ, Gurgel RQ, Coelho IC, Fontes CJF, Marques ETA, Romero GAS, Teixeira MM, Siqueira AM, Boaventura VS, Ramos F, Júnior EE, de Moraes JC, Whitehead SS, Esteves-Jaramillo A, Shekar T, Lee JJ, Macey J, Kelner SG, Coller BG, Boulos FC, Kallás EG; Phase 3 Butantan-DV Working Group. Nogueira ML, et al. Lancet Infect Dis. 2024 Nov;24(11):1234-1244. doi: 10.1016/S1473-3099(24)00376-1. Epub 2024 Aug 5. Lancet Infect Dis. 2024. PMID: 39116904 Clinical Trial.
The Association of ICU Acuity and Organizational Factors With Outcomes of Low-Risk Patients.
Salgueiro ES, Kurtz P, Borges LP, Bastos LSL, Zampieri FG, Burghi G, Melo UO, Corrêa TD, de Almeida SLS, de Marco FVC, Maia MO, Cravo VS, Pastore L Jr, de Freitas FGR, Santino MS, Saturnino SF, Lisboa TC, de Azevedo JRA, Varaschin PA, Veiga VC, Ferez MA, Boniatti MM, Rabahi MF, Machado FR, Antunes ARS, Ramos GV, Bozza FA, Salluh JIF, Spector N, Soares M; Organizational CHaractEriSTics in cRitical cAre (ORCHESTRA) Study Investigators. Salgueiro ES, et al. Crit Care Med. 2025 Apr 1;53(4):e817-e828. doi: 10.1097/CCM.0000000000006592. Epub 2025 Feb 7. Crit Care Med. 2025. PMID: 40758144
Anti-Trypanosoma cruzi activity of nicotinamide.
Soares MB, Silva CV, Bastos TM, Guimarães ET, Figueira CP, Smirlis D, Azevedo WF Jr. Soares MB, et al. Acta Trop. 2012 May;122(2):224-9. doi: 10.1016/j.actatropica.2012.01.001. Epub 2012 Jan 18. Acta Trop. 2012. PMID: 22281243 Free article.
Validation of the questionnaire of olfactory disorders (QOD) for the Brazilian population.
Bernardino ABCDS, Barreto-Filho MA, Pompeu AS, Andrade JDS, Azevedo ACA, Brasil MQA, Cedro M, Araújo C, Andrade N, Akrami K, Scussiatto HO, Boaventura VS, Fornazieri MA. Bernardino ABCDS, et al. Clinics (Sao Paulo). 2024 Jun 14;79:100414. doi: 10.1016/j.clinsp.2024.100414. eCollection 2024. Clinics (Sao Paulo). 2024. PMID: 38878322 Free PMC article.
Treatment of acute experimental schistosomiasis.
Andrade ZA, de Azevedo TM. Andrade ZA, et al. Mem Inst Oswaldo Cruz. 1989 Oct-Dec;84(4):477-84. doi: 10.1590/s0074-02761989000400004. Mem Inst Oswaldo Cruz. 1989. PMID: 2487444 Free article.
90 results